CCAAT/enhancer-binding protein δ (C/EBPδ) transcription factor is rapidly induced at an early stage of acute phase response. We previously reported that this induction was mainly mediated by acute phase response factor/signal transducers and activators of transcription 3 (APRF/STAT3). Furthermore, the high expression level of C/EBPδ is maintained by autoregulation mechanisms through the C/EBPδ binding sites located downstream of C/EBPδ gene. Thereafter, the expression of C/EBPδ gene decreases rapidly to the basal level. However, these mechanisms are still unknown. According to both transfection and DNA binding analyses, liver-enriched inhibitory protein (LIP), the shorter form of C/EBPβ and C/EBP-homologous protein 10 (CHOP10), were found to inhibit C/EBPδ gene expression. DNA binding analysis has further indicated that both LIP and CHOP10 form heterodimers with C/EBPδ, and inhibit the binding of C/EBPδ homodimer to the C/EBPδ binding sites located downstream of C/EBPδ gene. Taken together, these findings indicated that the maintained expression of C/EBPδ gene by autoregulation was inhibited and decreased to the basal level as a result of the competition of other C/EBP family proteins. Thus, C/EBPδ gene expression is mediated by the gene regulation circuit through the downstream C/EBPδ binding sites.
- CCAAT/enhancer-binding protein
- Gene expression
- Trans-acting factor
ASJC Scopus subject areas
- Pharmaceutical Science